| Dr Jessica Lynn Howard, DO | |
|
2401 Blueridge Ave Fl 2, Wheaton, MD 20902-4517 | |
| (301) 933-6440 | |
| Not Available |
| Full Name | Dr Jessica Lynn Howard |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2401 Blueridge Ave Fl 2, Wheaton, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871814186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | AF2495150-3196 (Virginia) | Secondary |
| 208000000X | Pediatrics | H0076213 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Lynn Howard, DO 6515 16th St N, Arlington, VA 22205-1835 Ph: (540) 230-8814 | Dr Jessica Lynn Howard, DO 2401 Blueridge Ave Fl 2, Wheaton, MD 20902-4517 Ph: (301) 933-6440 |
News Archive
Nanomedical Diagnostics, a cutting-edge life science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of a new NTA biosensor chip for use with its label-free Agile R100 assay system.
HHS Secretary Kathleen Sebelius has announced $70.9 million in grants to 13 states to support the expansion of health care coverage for their uninsured populations.
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Scientists at the Buck Institute have shown that mice suffering from a depletion of the antioxidant glutathione in dopamine-producing neurons developed nerve damage and symptoms associated with Parkinson's disease (PD) in humans.
› Verified 9 days ago
Dr. Earlene Jordan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Blueridge Ave Ste 210, Wheaton, MD 20902 Phone: 301-933-6440 Fax: 301-933-5923 | |
Terisa Lynn Foster Flick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Blueridge Ave, Suite 210, Wheaton, MD 20902 Phone: 301-933-6440 | |
Dr. Jennifer Sue Buchanan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Blueridge Ave, #210, Wheaton, MD 20902 Phone: 301-933-6440 Fax: 301-933-5923 | |
Ann Starchman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Blueridge Ave, Suite 210, Wheaton, MD 20902 Phone: 301-933-6440 Fax: 301-933-6440 | |
Dr. Samuel Harris Leibowitz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Blueridge Ave, Suite 210, Wheaton, MD 20902 Phone: 301-933-6440 Fax: 301-933-5923 | |
Dr. Jose D Villagra, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2730 University Blvd W Ste 410, Wheaton, MD 20902 Phone: 240-669-6330 Fax: 240-669-6757 | |
Deborah Erin Engel, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Blueridge Avenue, Wheaton, MD 20902 Phone: 301-933-6440 Fax: 301-933-5923 |